Daily Financial Update
Quick Take
Market Pulse: Markets are ripping into a year-end rally on broad optimism that regulators and earnings beats will fuel a late surge.
Key Movers: TeraWulf’s Q3 revenue bump and IREN’s pivot into high-performance AI gear are stealing the headlines, while Under Armour’s core gains defy the Curry split.
Macro & Politics: Washington’s budget gridlock is parked until next session and FDA watchers are zooming in on “Ozempic 2.0” as a potential game-changer for life sciences portfolios.
What’s Next: Eyes on FDA nods and next week’s earnings catalysts—your portfolio’s late sprint depends on it.
Market Commentary
Everyone’s overlooking the real leverage in TeraWulf and IREN beyond the headlines. While Biztoc.com spotlighted TeraWulf’s $50.6 million Q3 revenue and Citizens’ IREN outperform call, they’re missing that these rigs now chasing AI earnings could trigger a bigger re-rating than any short-squeeze chatter. That’s the sneaky catalyst nobody’s talking up while they obsess over self-mined Bitcoin dips.
Imagine blending Under Armour’s unexpected core strength (Yahoo Entertainment flagged the silent win post-Curry exit) with CRISPR’s FDA buzz, as Citizens keeps the gene-editing story alive despite Casgevy headwinds. That pairing suggests a broader thesis: consumer brands and cutting-edge biotech both thrive on momentum resets, and they’ll outpace the herd as soon as the next approval or partnership hits.
Positioning now means balancing your bets between high-power computing plays and life-sciences catalysts—stay nimble. Don’t just watch the year-end rally; prep for the overnight shocks in FDA rulings and tech pivots that will decide who’s laughing come January.
📈 Breaking Financial News
Q3 Revenue Reaches $50.6 Million Amid Self-Mined Bitcoin Decline, Citizens Maintains Market Outperform Rating
TeraWulf Inc. (NASDAQ:WULF) ranks among the best short squeeze stocks to buy right now. Following TeraWulf Inc. (NASDAQ:WULF)’s third-quarter 2025 earnings…
Citizens Initiates Market Outperform on IREN Limited (IREN) as it Shifts Focus from Bitcoin Mining to AI High-Performance Computing
REN Limited (NASDAQ:IREN) ranks among the best short squeeze stocks to buy right now. On November 19, Citizens began coverage of IREN Limited (NASDAQ:IREN)…
Strengthens Core Business Despite Curry Partnership Ending
Under Armour Inc. (NYSE:UA) ranks among the best short squeeze stocks to buy right now. Telsey Advisory Group announced on November 18 that Under Armour Inc. (NYSE:UA) and basketball player Stephen Curry will part ways in 2026 after a 12-month wind-down perio…
Strengthens Core Business Despite Curry Partnership Ending
Under Armour Inc. (NYSE:UA) ranks among the best short squeeze stocks to buy right now. Telsey Advisory Group announced on November 18 that Under Armour Inc. (NYSE:UA) and basketball player Stephen Curry will part ways in 2026 after a 12-month wind-down perio…
Under Armour (UA) Strengthens Core Business Despite Curry Partnership Ending
Under Armour Inc. (NYSE:UA) ranks among the best short squeeze stocks to buy right now. Telsey Advisory Group announced on November 18 that Under Armour Inc….
Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse With new executi
Institutions are loading up while it still trades at a discount. Get the full intelligence for just $3.
🔍 Market Analysis & Insights
TeraWulf (WULF) Q3 Revenue Reaches $50.6 Million Amid Self-Mined Bitcoin Decline, Citizens Maintains Market Outperform Rating
TeraWulf Inc. (NASDAQ:WULF) ranks among the best short squeeze stocks to buy right now. Following TeraWulf Inc. (NASDAQ:WULF)’s third-quarter 2025 earnings…
Citizens Initiates Market Outperform on IREN Limited (IREN) as it Shifts Focus from Bitcoin Mining to AI High-Performance Computing
REN Limited (NASDAQ:IREN) ranks among the best short squeeze stocks to buy right now. On November 19, Citizens began coverage of IREN Limited (NASDAQ:IREN)…
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its Market Outperform rating and $86 price target for CRISPR Therapeutics AG (NASDAQ:CRSP) on November 11. The firm discussed positive finding…
Citizens Maintains Market Outperform on CRISPR Therapeutics (CRSP) Despite Casgevy Slowdown
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its Market Outperform rating and $86…
TD Cowen Reiterates Buy on SailPoint (SAIL) Ahead of Q3 Earnings
SailPoint, Inc. (NASDAQ:SAIL) ranks among the best short squeeze stocks to buy right now. On November 18, TD Cowen reiterated its Buy rating and $30 price…
Bitcoin In Serious Danger of Disappearing From Exchanges…
This could be the biggest “supply shock” in financial history! Bitcoin on exchanges is being bought up faster than miners can mine it. The smart money like BlackRock, Goldman Sachs, and MicroStrategy are doubling, tripling, quadrupling down. And they're doing everything they can to buy up ONE altcoin before prices blast-off like a Space X rocket. Discover the ONE altcoin smart money is buying up before Bitcoin's supply shock.
💰 Investment Opportunities
Plug Power (PLUG) Eyes Expansion in Energy Markets, TD Cowen Maintains Buy
Plug Power Inc. (NASDAQ:PLUG) ranks among the best short squeeze stocks to buy right now. On November 19, TD Cowen maintained its Buy rating for Plug Power…
Daiwa Securities Maintains Buy as Centrus Energy (LEU) Plans $1 Billion ATM Offering
Centrus Energy Corp. (NYSE:LEU) ranks among the best short squeeze stocks to buy right now. Following a post-earnings non-deal roadshow with management on…
Jim Cramer Highlights a “Great Quarter From Best Buy”
Best Buy Co., Inc. (NYSE:BBY) is one of the stocks Jim Cramer recently talked about. Cramer highlighted the reason why the stock rallied. He commented: “This…
Year-End Rally Begins
At a Glance
- Rally Into Year-End As Dip Buyers Emerge?
- Year-End Rally Begins
- Portfolio Tactics For Next Week
- From Lance's Desk: Market Bubbles: A Rational Guide To An Irrational …
Buffett, Gates and Bezos Quietly Dumping Stocks-Here's Why The world's wealthies
Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It's something we haven't see in America for more than a century. For the full story, click here.